CYRX vs RARE · rev $96.8M vs rev $350.0M
Cryoport Inc (CYRX) versus Ultragenyx (RARE) — a side-by-side from cached financials, not a winner call.
Cryoport Inc (CYRX) is a integrated freight & logistics company listed on US.
Ultragenyx (RARE) is a biotechnology company listed on US.
Latest reported CYRX revenue for 2026-06-30 was $96.8M. Net income was -$18.8M. CYRX currently screens at market cap $365.5M.
Latest reported RARE revenue for 2026-06-30 was $350.0M. Net income was -$277.0M. RARE currently screens at market cap $2.79B.
CYRX currently screens at market cap $365.5M. RARE currently screens at market cap $2.79B.
Not investment advice. Open the CYRX and RARE stock pages for the full models.
Not investment advice.